These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18997141)

  • 1. Prescribing by pharmacists in Alberta.
    Yuksel N; Eberhart G; Bungard TJ
    Am J Health Syst Pharm; 2008 Nov; 65(22):2126-32. PubMed ID: 18997141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The road to pharmacist prescribing in Alberta Health Services.
    Gray M; Mysak T
    Am J Health Syst Pharm; 2016 Sep; 73(18):1451-5. PubMed ID: 27605324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of pharmacist prescribing practices in Alberta.
    Guirguis LM; Hughes CA; Makowsky MJ; Sadowski CA; Schindel TJ; Yuksel N
    Am J Health Syst Pharm; 2017 Jan; 74(2):62-69. PubMed ID: 28069679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How have pharmacists in different practice settings integrated prescribing privileges into practice in Alberta? A qualitative exploration.
    Guirguis LM; Makowsky MJ; Hughes CA; Sadowski CA; Schindel TJ; Yuksel N
    J Clin Pharm Ther; 2014 Aug; 39(4):390-8. PubMed ID: 24805908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What prescribing means to pharmacists: a qualitative exploration of practising pharmacists in Alberta.
    Hughes CA; Makowsky M; Sadowski CA; Schindel TJ; Yuksel N; Guirguis LM
    Int J Pharm Pract; 2014 Aug; 22(4):283-91. PubMed ID: 25121165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of additional prescribing authorization among oncology pharmacists in Alberta.
    Au B; Dersch-Mills D; Ghosh S; Jupp J; Chambers C; Cusano F; Danilak M
    J Oncol Pharm Pract; 2019 Apr; 25(3):584-598. PubMed ID: 29338572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provincial Comparison of Pharmacist Prescribing in Canada Using Alberta's Model as the Reference Point.
    Bhatia S; Simpson SH; Bungard T
    Can J Hosp Pharm; 2017; 70(5):349-357. PubMed ID: 29109578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing by pharmacists in Alberta and its relation to culture and personality traits.
    Rosenthal MM; Houle SK; Eberhart G; Tsuyuki RT
    Res Social Adm Pharm; 2015; 11(3):401-11. PubMed ID: 25315135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An explanatory policy analysis of legislative change permitting pharmacists in Alberta, Canada, to prescribe.
    MacLeod-Glover N
    Int J Pharm Pract; 2011 Feb; 19(1):70-8. PubMed ID: 21235661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacist as prescriber: a discourse analysis of newspaper media in Canada.
    Schindel TJ; Given LM
    Res Social Adm Pharm; 2013; 9(4):384-95. PubMed ID: 22835707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAPABLE: Calgary zone usage of Additional Prescribing Authorization By pharmacists in an inpatient setting: review of the prescribing Landscape and Environment.
    Saunders S; Dersch-Mills D; Mysak T; Romonko-Slack L; Chernick A; Lazarenko G; Zuk D
    Res Social Adm Pharm; 2020 Mar; 16(3):342-348. PubMed ID: 31227474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of Alberta hospital pharmacists' perspectives on additional prescribing authorization.
    Hutchison M; Lindblad A; Guirguis L; Cooney D; Rodway M
    Am J Health Syst Pharm; 2012 Nov; 69(22):1983-92. PubMed ID: 23135565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceptions of Saskatchewan community pharmacists regarding a prior-authorization program.
    Perepelkin J; Dobson RT
    J Manag Care Pharm; 2007 Sep; 13(7):589-97. PubMed ID: 17874865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The availability of pharmacists with Additional Prescribing Authorization in relation to the distribution of vulnerable populations - A cross-sectional study.
    Alsabbagh MW; Houle SKD; Waite NM
    Res Social Adm Pharm; 2020 Jan; 16(1):84-89. PubMed ID: 31000334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and implementation of the compensation plan for pharmacy services in Alberta, Canada.
    Breault RR; Whissell JG; Hughes CA; Schindel TJ
    J Am Pharm Assoc (2003); 2017; 57(4):532-541. PubMed ID: 28623124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Opinions and attitudes of Flemish pharmacists and general practitioners towards INN prescribing. A survery in Antwerp and East Flanders].
    Fraeyman J; De Winter J; De Loof H; Van Hal G; Beutels P; Remmen R; De Meyer GR
    J Pharm Belg; 2013 Jun; (2):18-31. PubMed ID: 23798183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On-the-ground application of the 'temporary recommendation for use' regulatory measure on off-label use of baclofen for alcohol dependence in France: a regional survey of community pharmacies.
    Auffret M; Rolland B; Caous AS; Gaboriau L; Deheul S; Bordet R; Gautier S
    Fundam Clin Pharmacol; 2018 Apr; 32(2):234-238. PubMed ID: 29143356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent prescribing by hospital pharmacists: Patterns and practices in a Canadian province.
    Heck T; Gunther M; Bresee L; Mysak T; Mcmillan C; Koshman S
    Am J Health Syst Pharm; 2015 Dec; 72(24):2166-75. PubMed ID: 26637516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How pharmacists check the appropriateness of drug therapy? Observations in community pharmacy.
    Nusair MB; Guirguis LM
    Res Social Adm Pharm; 2017; 13(2):349-357. PubMed ID: 27102265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prescription adaptation by pharmacists.
    Law MR; Morgan SG; Majumdar SR; Lynd LD; Marra CA
    BMC Health Serv Res; 2010 Nov; 10():313. PubMed ID: 21083922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.